Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

NCT01929720

Conditions: Adnexal Diseases, Anxiety Disorder, Anxiety Disorders, +85 more
Locations: Wexner Medical Center at The Ohio State University Department of Psychiatry Columbus, Ohio, United States

View Trial Details

Completed

Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)

NCT00732641

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

NCT02129569

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

NCT01626547

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy-induced Symptomatic Anaemia, +17 more
Locations: Alzey, Germany

Bad Säckigen, Germany

Berlin, Germany

Berlin, Germany

View all 39 locations

View Trial Details

Completed

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

NCT00577642

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

NCT00143845

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

NCT00307086

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma

NCT01019174

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University Clinic München-Großhadern München, Germany

University of Münster, Department of Hematology/Oncology Münster, Germany

Tübingen University, Department of Hematology/Oncology/Immunology Tübingen, Germany

University Clinic Ulm, Department Internal Medicine Ulm, Germany

View Trial Details

Completed

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00091260

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00679367

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Boston University Cancer Research Center Boston, Massachusetts, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions